Gregory A. Bonfiglio, Managing Partner at Proteus Venture Partners to Give Featured Presentation at 5th Stem Cell Research & Therapeutics Conference

Monrovia, CA, December 31, 2008 --(PR.com)-- Gregory A. Bonfiglio, Managing Partner at Proteus Venture Partners will give the featured address entitled “Commercialization of Regenerative Medicine: Translating Great Science into Successful Business.” at GTCbio’s 5th Stem Cell Research & Therapeutics Conference on March 9-10, 2009 in Boston, MA.

Mr. Bonfiglio will review current funding environment for Regenerative Medicine Companies, and will try to place that environment in context of historical market trends. He will discuss various funding sources, both public and private and examine the venture process, the criteria used by investors for making funding decisions, and typical deal structures. Finally, he will review the major challenges involved in the commercialization of Regenerative Medicine technologies.

Other notable presenters at the conference include Dr. Rudolf Jaenisch, Founding Member of the Whitehead Institute and Professor of Biology at MIT and Dr. Leonard Zon, Director of the Stem Cell Program at Children’s Hospital Boston and Investigator at the Howard Hughes Medical Institute.

GTCbio's 5th annual conference on Stem Cell Research and Therapeutics provides stem cell researchers with a comfortable environment to exchange ideas and brainstorm on novel pathways to discovery. Leading experts in the field will present unreleased information and attendees will learn the most up-to-date developments in this arena. For more information visit http://gtcbio.com/conferenceDetails.aspx?id=145.

###